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 Nail-patella syndrome (NPS; OMIM 161200), also
known as onychoosteodysplasia, Turner-Kieser syndrome, or
Fong disease is a rare heterogeneous, autosomal-dominant
pleiotropic disorder characterized by skeletal abnormalities
such as nail dysplasia and hypoplastic patellae, renal disease,
and open-angle glaucoma (OAG) [1-3]. More than 60 muta-
tions in the LMX1B gene have been associated with NPS, which
has a high intra- and interfamily degree of heterogeneity [4,5].
The identification of the causative gene for this syndrome,
the LIM-homeodomain transcription factor LMX1B, led to in-
vestigation of the phenotype and molecular pathogenesis in
different target organs in NPS patients [6-8]. The LMX-
homeodomain proteins are a family of transcription factors
frequently involved in pattern formation during embryonic
development [9,10]. The LMX1B gene encodes a transcrip-
tion factor protein that contains two zinc-binding LIM domains
(A and B) at the NH2-terminus and one homeodomain in the
middle, which is responsible for the binding to DNA [11-13].
Most of the mutations reported lead to the absence or inacti-
vation of the homeodomain, resulting in a protein unable to
recognize its target genes [14,15].
The LMX1B transcription factor protein is involved in
normal patterning of the dorsoventral axis of the embryo dur-
ing development [9,10] and early morphogenesis of the glom-
erular basement membrane [16]. Molecular studies and ge-
netic immunochemical experiments carried out in the lmx1b-
/- mouse model for NPS showed the involvement of lmx1b in
the transcription regulation of different alpha chains of type
IV collagen in renal podocytes [17,18]. The defect in collagen
fibrillogenesis is also seen in the cornea of lmx1b-/- mutant
mice, thus supporting the role of LMX1B in collagen regula-
tion. These collagen defects in the eye could be responsible
for the presence of glaucoma in NPS patients [19].
NPS is caused by a mutation in the LMX1B gene that pre-
sumably leads to loss of function of the encoding transcrip-
tion factor, and the clinical phenotype is related to the pleio-
tropic effect of LMX1B during development [20,21]. It has
been suggested that as the LMX1B gene encodes a LIM
homeodomain transcription factor, which contributes to tran-
scriptional regulation of glomerular membrane collagen ex-
pression by podocytes, both renal and ocular malformations
could result from the same alteration during embryogenesis.
Many articles have cited the presence of OAG or ocular
hypertension (OHT) as one of the features of NPS but the
clinical details of this type of glaucoma have never been fully
described. Recently, there has been an important advance in
glaucoma diagnostic tools with the appearance of new imag-
ing devices of the optic nerve head (ONH) and retinal nerve
fiber layer (RNFL), such as optical coherence tomography
(OCT) [22]. Moreover, the role of pachymetry in the differen-
tial diagnosis of OHT and glaucoma is progressively gaining
more importance [23] prior to initiating expensive hypoten-
sive treatments that can cause discomfort and side effects in
these patients.
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Our study had two aims: (1) to screen a seven-generation
NPS Spanish family for mutations in the LMX1B gene; and
(2) to characterize the clinical phenotype of their OAG or OHT
by performing new structural optic disc examinations such as
OCT.
METHODS
Patients:  Prior to their inclusion in this study, all participants
were informed of its objectives. A total of 18 family members
(12 women and 6 men) ranging in age from 7 to 90 years were
analyzed. All gave their informed consent to participate in the
study, which adhered to the tenets of the Declaration of
Helsinki. Affected and unaffected members of a NPS Spanish
family underwent a complete ophthalmologic examination and
DNA genetic analysis. During the physical examination, some
patients mentioned they were receiving topical glaucoma medi-
cations. After the initial examination, all patients were sched-
uled for several follow-up visits over three years. One patient,
(IV-1), died a few months after the initial visit before under-
going other tests, such as pachymetry or OCT.
Molecular genetics:  Blood samples were drawn for DNA
analysis. Genomic DNA was prepared from peripheral blood
lymphocytes using QIAmp DNA blood mini kit (Qiagen,
Valencia, CA). The coding region of the LMX1B (NM_00231)
gene was amplified using primers located in the flanking in-
tron region. Further amplification of exon 3 of LMX1B was
carried out using 5'-CTG GGA GGG ACT TCT GAG CA-3'
as the forward primer and 5'-CTC CAG GAC ACC CCA GCA
AC-3' as the reverse primer. A “CG clamp”, consisting of a
sequence of 40 CG nucleotides, was included in the 5' sequence
of the forward primer, 5'-CCT CCA GGA CAC CCC AGG
AA-3', to provide better resolution in the denaturing gradient
gel electrophoresis (DGGE) analysis [24]. Polymerase chain
reaction (PCR) was performed in a 50 µl volume of buffer (20
mM Tris-HCl, pH 8.55; 16 mM (NH)2SO4; 1.5 mM MgCl2;
150 µg/ml BSA) containing 200-500 ng of human genomic
DNA, 25 picomols of each primer, 10 nanomols of each
deoxyribonucleoside triphosphate, and 1.5 units of Taq poly-
merase (Ecotaq). Incubation was performed for 40 cycles con-
sisting of 1 min at 94 °C, 1 min at 50 °C, and 1 min at 72 °C;
this was followed by 1 min at 94 °C and 5 min at 72 °C. Elec-
trophoresis of 8 µl of final PCR reaction volume was per-
formed on 1.5% agarose gel to test the amplification reaction.
For DNA sequencing, PCR products were purified using
Qiaquick columns (Qiagen). DNA sequencing was carried out
using the OpenGene automated DNA sequencing system from
Visible Genetics and Thermo Sequenase Cy5.5 Dye Termina-
tor Cycle Sequencing kit (Amersham Pharmacia Biotech,
Barcelona, Spain). The sequencing primers were the same as
those used for the PCR reaction.
Eye examination:  The personal and family medical his-
tory of each patient was critical for determining which indi-
vidual was affected and for establishing the inheritance pat-
tern. Details about other systemic NPS anomalies were ob-
tained from the each participant’s medical chart. A compari-
son of the severity of systemic manifestations between the
family members was performed to establish a spectrum of
systemic involvement.
Best corrected visual acuity (BCVA) was tested with
Snellen charts, and ocular refraction was evaluated with an
autorefractometer. Biomicroscopy of the anterior segment was
performed. Tonometry was done with a Goldmann applana-
tion tonometer, using the mean of three consecutive tonom-
etry readings for each eye. Gonioscopy with a Goldmann three-
mirror lens and funduscopy for the observation of the ONH
and peripapillary region under direct examination with a 78 D
Volkmann lens completed the slit-lamp exam.
Ancillary examinations:  All cases underwent computer-
ized perimetry with two types of perimeters to confirm the
accuracy of the data. We used a 750-Humphrey field analyzer
II following a SITA Standard strategy and an Octopus 101
perimeter, TOP strategy. We used a size III stimulus and a
white-on-white test for both devices.
Monoscopic ONH and peripapillary RNFL digital pic-
tures were taken with a Topcon nonmydriatic retinal camera
(Topcon model TRC-NW6S, Topcon, Tokyo, Japan).
Ultrasound pachymetry was performed under topical an-
esthesia with an Ocuscan RxP pachymeter (Alcon Laborato-
ries Inc., Irvine, CA) that provides six central readings and
calculates the mean value. The intraocular pressure (IOP) is
then manually introduced in each case and the machine auto-
matically provides a new IOP value corrected for the
pachymetry measurements (Herndon Formula).
Optical coherence tomography was performed with OCT
version 3 (Stratus OCT, Carl Zeiss Meditec Inc., Dublin, CA),
which is a high-resolution cross-sectional imaging technique
that allows in vivo measurements of the RNFL (described fur-
ther in reference [25]). All subjects received pupillary dilata-
tion with 0.5% tropicamide.
Patients underwent three different protocols: fast RNFL
thickness, fast ONH, and fast macular thickness measurements.
The studied parameters in each protocol (average thickness,
superior average thickness, inferior average thickness, verti-
cally integrated rim area, horizontally integrated rim width,
cup/disc area ratio, inferior outer macula, and temporal outer
macula) were the most relevant for the glaucoma diagnosis
according to the study by Medeiros; as all had receiver oper-
ating characteristic (ROC) curves above 0.75 except the disc
area that was included in our study for demographic purposes
[22].
In all protocols only images with a quality above 7 were
accepted. Exams were repeated until this level was reached.
RESULTS
Genetic analysis:  We screened for mutations in all of the ex-
onic and flanking sequences of LMX1B: (NM_002307) in the
index case of an NPS family. A DGGE alteration pattern was
detected in exon 3 of this index patient but absent in 56 unre-
lated controls. Direct genomic sequencing revealed the dele-
tion of one G (289delG) within the coding sequence of exon 3
at codon 97 of LMX1B (Figure 1). This nucleotide deletion
changes the open reading frame of the gene, creating a prema-
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Figure 1. Genetic results of the NPS family.  A: Pedigree of a Span-
ish family with nail-patella syndrome (NPS). Filled squares and circles
denote NPS-affected males and females, respectively. Open squares
and circles represent males and females without NPS. A diagonal
line through the symbols marks a deceased individual. An arrow in-
dicates the index patient (VI-4). The following symbols were used:
wild-type allele (+)2889delG allele (-), and 372A>G allele (x), cor-
respond to a, and allele, respectively. B: Denaturing gradient gel elec-
trophoresis (DGGE) of the PCR fragment of exon 3. The different
electrophoretic profiles correspond to carriers of the following:
289delG/WT (IV-1, IV-2, IV-3, V-1, V-2, V-6, and VI-2); WT/372A>G
(V-3, VI-1, VI-6, VI-7); 289delG/372A gt G (V-5, V-9, VI-4); WT/
WT (V-4, V-8, VI-3) and 372A>G/372A>G (VI-5). WT=wild type.
C: DNA genomic sequencing of exon 3 of LMX1B showing the
289delG mutation (left) and a control DNA (right).
641ture stop at codon 105 (E97fsX105), presumably giving rise
to a truncated protein. Both DGGE analysis and sequencing
of exon 3 were carried out in all members of this family. Analy-
sis of the family revealed that several members carried a novel
nucleotide change 372 A>G that generates the silent mutation
Glu124Glu (data not shown). Because mutations 289delG and
372>G in LMXB1 segregate separately, as deduced by DGGE
and sequencing analysis, both mutations would be in separate
chromosomes (different alleles). It has been hypothesized that
the severity of the NPS may also be related to the second copy
of LMXB1 gene [3]. In this large family we cosegregated both
alleles (containing the NPS and the silent mutation), but no
evidence supporting the hypothesis of a second allele interac-
tion could be found.
Ten family members had NPS with varying degrees of
systemic involvement (Table 1), although one NPS member
died (IV-1) during follow-up. The inheritance pattern was au-
tosomal dominant with complete penetrance but variable
expressivity (Figure 1). Onychodysplasia (Figure 2) and pa-
tellar hypoplasia were the only signs present in all the pa-
tients.
Nephropathy (glomerulonephritis) and colon disease
(spasmodic colitis) appeared in only a few members. Differ-
ent skeletal abnormalities were observed in some members of
the family: Patients V-5 and VI-4 showed hip subluxation, and
patient VI-4 also had generalized joint hyperextensibility, par-
ticularly in the fingers. Some patients described generalized
muscular pains (V-5, VI-2, VI-4) and chronic fatigue (V-5).
The severity of the systemic involvement of NPS was unre-
lated to patient age, with the index patient being not only the
youngest but also one of the most seriously affected.
Ophthalmologic features:  Seven of the NPS patients re-
ported having OAG were treated by their ophthalmologists
with one or two topical hypotensive drugs. Five of these com-
plained of ocular side effects such as conjunctival hyperemia,
itching, iris hyperpigmentation, and eyelash growth. These are
well known common side effects of such hypotensive agents
(Table 2).
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Figure 2. Gonioscopy of NPS patients.  A: Color photograph taken during gonioscopy of multiple iris processes in patient V-6. B: Color
photograph of a highly pigmented anterior chamber angle of patient V-9.
TABLE 1. SYSTEMIC PHENOTYPE OF NPS FAMILY
                                                    Other                                 OAG
                        Nail      Hypoplastic     skeletal         Colon                  or
Patient   Age   Sex   dysplasia    patellae     abnormalities   nephropathy   Anomalies   OHT
-------   ---   ---   ---------   -----------   -------------   -----------   ---------   ---
IV-1      86     F        +            +              +              +            -        +
IV-2      72     M        +            +              +              -            -        +
IV-3      67     F        +            +              +              -            +        +
V-1       60     M        +            +              +              -            +        +
V-2       56     F        +            +              +              -            -        -
V-5       46     F        +            +              +              -            -        +
V-6       41     F        +            +              +              +            -        +
V-9       29     M        +            +              -              -            -        +
VI-2      32     F        +            +              +              -            -        -
VI-4      28     F        +            +              +              +            +        -
Systemic anomalies of all nail-patella syndrome (NPS) patients evaluated in this study. The following terms were used: F refers to female, M
refers to male, OAG is open angle glaucoma, and OHT is ocular hypertension.
642BCVA was severely diminished in the eldest patient due
to diabetic retinopathy with macular edema (IV-1). Two pa-
tients with cataracts (IV-2, IV-3) underwent uneventful bilat-
eral phacoemulsification, and their BCVA was unremarkable
in the postoperative period. A 48-year-old patient (V-5) pre-
sented with mild lens opacities that caused a certain degree of
visual loss, suggesting the presence of congenital cataracts.
The refractive status of all patients was within the normal range
(data not shown).
Subjects receiving topical hypotensive medications were
asked to stop their medications for a wash-out period of three
to four weeks in order to establish a baseline intraocular pres-
sure. Gonioscopy revealed the presence of multiple iris pro-
cesses (Figure 2A) in the majority of the OAG patients and a
highly pigmented trabeculum was also quite common, mark-
edly so in one case (V-9; Figure 2B). No dysplastic changes
or presence of abnormal vessels were noticed. All had wide,
open anterior chambers and angles measured more than 45°,
except in one case of 30°in both eyes (V-5).
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TABLE 3. STRATUS OPTICAL COHERENCE TOMOGRAPHY DATA OF NAIL-PATELLA SYNDROME PATIENTS
                                                                                       Fast
                                                   Fast ONH protocol                  macula
              Fast RNFL protocol     ---------------------------------------------   protocol
             ---------------------                   Disc     Cup     C/D     Rim    ---------
Case   Eye     AT       ST     IT    VIRA    HIRW    area    area    ratio   area    IOM   TOM
----   ---   ------   ------   ---   -----   -----   -----   -----   -----   -----   ---   ---
IV-2   OD    111.03   111      158   0.311   1.687   2.504   0.735   0.294   1.769   219   216
       OS    119.53   143.03   154   0.383   1.866   3.094   0.943   0.305   2.151   243   226
IV-3   OD    94.24    127      113   0.169   1.327   2.403   1.009   0.42    1.394   187   188
       OS    107.80   129      128   0.289   1.625   2.606   0.772   0.296   1.836   237   233
V-1    OD    94.29    134      106   0.022   0.492   2.941   2.386   0.811   0.555   205   209
       OS    99.52    136      134   0.142   1.584   3.735   2.486   0.666   1.249   219   215
V-2    OD    98.88    121      138   0.984   1.923   2.254   0       0       2.254   213   209
       OS    100.78   117      150   1.085   2.096   2.033   0       0       2.033   218   219
V-5    OD    118.52   160      139   0.205   1.664   2.745   1.4     0.51    1.345   239   222
       OS    111.38   138      139   0.258   1.754   2.751   1.206   0.438   1.545   251   216
V-6    OD    106.65   134      139   0.32    1.807   2.813   1.056   0.375   1.757   226   235
       OS    106.77   130      139   0.211   1.495   2.337   1.206   0.516   1.131   224   231
VI-2   OD    113.29   158      146   0.995   2.234   2.939   0.304   0.103   2.635   226   217
       OS    119.88   174      155   1.583   2.668   3.5     0.537   0.153   2.963   230   216
V-9    OD    111.75   142      141   0.265   1.635   2.485   1.224   0.493   1.261   237   218
       OS    115.15   146      147   0.29    1.827   2.965   1.227   0.414   1.738   232   211
VI-4   OD    135.54   163      199   0.788   2.434   3.102   0.683   0.22    2.419   243   226
       OS    126.03   179      181   0.735   2.613   4.209   1.291   0.307   2.918   248   232
The measurement numbers in red show thickness measurements above the normal range; the rest of the boxes show normal measurements.
The following abbreviations were used: retinal nerve fiber layer (RNFL), optic nerve head (ONH) average thickness (AT), superior average
thickness (ST), inferior average thickness (IT), vertically integrated rim area (VIRA), horizontally integrated rim width (HIRW), cup/disk area
ratio (C/D ratio), inferior outer macula (IOM), and temporal outer macula (TOM). All values are expressed in mm except VIRA (mm3) and
HIRW (mm2).
TABLE 2. OPTHTHALMOLOGIC FEATURES OF NPS PATIENTS
         LMX1B     VA    VA    IOP   IOP   PACH   PACH   C IOP   C IOP   C/D   C/D
Case   haplotype   OD    OS    OD    OS     OD     OS     OD      OS     OD    OS
----   ---------   ---   ---   ---   ---   ----   ----   -----   -----   ---   ----
IV-1      -/+      LP    HM    30    30     -      -       -       -     0.9   0.9
IV-2      -/+      0.4   0.3   26    24    581    591     23      20     0.3   0.3
IV-3      -/+      0.5   0.4   23    25    569    568     21      23     0.3   0.3
V-1       -/+      1     1     25    23    592    585     21      20     0.8   0.55
V-2       -/+      1     1     17    18    597    592     13      14     0.1   0.1
V-5       -/x      0.8   0.6   25    23    555    564     24      22     0.4   0.6
V-6       -/+      1     1     26    24    584    586     23      20     0.6   0.7
V-9       -/x      1     1     23    24    659    644     16      17     0.6   0.6
VI-2      -/+      1     1     18    19    596    590     14      15     0.1   0.1
VI-4      -/x      1     1     18    20    646    636     11      13     0.1   0.1
Ophthalmologic features of all nail-patella syndrome (NPS) patients with either open angle glaucoma or ocular hypertension. The following
abbreviations were used: visual acuity (VA), right eye (OD), left eye (OS), light perception (LP), hand motion (HM), baseline intraocular
pressure (IOP; in mmHg), pachymetry (PACH; in µm), pachymetry corrected IOP (C IOP), and cup/disc ratio (C/D). The following symbols
were used in the LMX1B haplotype column: wild-type allele (+), 2889delG allele (-), and 372A>G allele (x).
643One patient (V-1) presented with vertical saucerization in
his right ONH and bilateral optic disc asymmetry, defined by
a difference greater than 0.2 with left eye cupping. The eldest
patient (IV-1) presented with a cup/disc ratio of 0.9, bayonet-
ing of vessels and severe pallor, suggesting advanced glau-
coma neuropathy.
Ultrasound pachymetry displayed high readings in all NPS
patients in contrast with other non-NPS family members who
had mean pachymetry readings of 530±3 µm.
Computerized perimetry was unremarkable in seven pa-
tients. Two (IV-2, IV-3) had diffuse decreased sensitivity due
to their senile cataracts and presented with normal visual field
testings after their cataract extraction. Patient V-5 had an ini-
tial inferior arcuate scotomata in both eyes, more marked in
her right eye and mild diffuse loss due to congenital lens opac-
ity (Octopus data in decibels (dB): MD 3.7; LV 9.9, OD/MD
2.2, LV 6.4 OS, and Humphrey perimeter data in dB: MD -
5.14, DSM 3.57, OD/MD -2.40, DSM 2.09 OS). Patient IV-1
could not perform this test due to her severe low vision.
Stratus optical coherence tomography data:  The Fast
RNFL protocol showed extraordinary high thickness measure-
ments through consecutive OCT tests (Table 3), showing that
the peripapillary nerve fiber layer was thicker in these patients
than in the normal population (data from 350 controls col-
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Figure 3. Optical coherence tomogra-
phy of patients IV-2 and V-1.  A: Opti-
cal coherence tomography (OCT) dia-
gram for patient IV-2 in which above-
normal retinal nerve fiber layer
(RNFL) thickness measurements are
expressed in white in the pie chart.
Green sectors are within the normal
range. B: OCT Fast optic nerve head
protocol of patient V-1, confirming cup
enlargement.
644lected on the hard disk of the OCT machine). Five NPS pa-
tients (four with OHT and one normotensive) presented with
mean thickness measurements in the “white zone” of the OCT
plot (Figure 3A).
The Fast ONH protocol provided measurements of optic
disc and cup diameters, volumes, and ratios that were also
unremarkable except in patient V-I (Figure 3B). This patient
presented with a pathologic cup/disc (C/D) area ratio in his
OD (0.8) and bilateral asymmetry above 0.2 (C/D ratio 0.6
OS).
The Fast macular thickness protocol provided completely
normal results for all the patients.
Glaucoma therapeutic approach:  Patient IV-I had been
previously diagnosed with severe OAG based on tonometry
and optic disc aspect and was under treatment with two drugs
until she died.
Patients IV-2 and IV-3 were diagnosed with OHT or
preperimetric OAG, and their topical hypotensive drugs were
stopped. They presented normal perimetry and OCT at fol-
low-up examinations after bilateral phacoemulsification.
Patient V-1 was diagnosed with glaucoma suspect upon
optic nerve asymmetry between both eyes, confirmed by the
C/D area ratio provided by OCT. He is being treated with one
hypotensive drug (prostaglandin analog nightly).
Patient V-2 and her two daughters (VI-2, VI-4) were con-
sidered as non-OHT NPS patients.
Patient V-5 was deemed to have glaucoma based on the
IOP readings and initial arcuate perimetry lesions, although
the optic nerves were not apparently affected according to their
aspect and the OCT. She is currently receiving hypotensive
treatment with a prostaglandin analog and, as she is develop-
ing cataracts, will be scheduled for phacoemulsification.
Patients V-6 and V-9 were diagnosed with OHT because
their IOPs were above 20 mmHg but less than 30 mmHg. Their
ophthalmologic explorations were otherwise unremarkable.
They currently remain without treatment.
DISCUSSION
 We screened an index case from a large Spanish family with
NPS for mutations in the LMX1B gene and found a novel non-
sense mutation, 289delG, causing a premature stop at codon
105 (E97fsX105). The mutation is located in exon 3 of LMX1B,
which encodes the COOH-terminal region of the LIM-A do-
main. Thus, in the putative-encoded mutant protein, the lack
of the LIM-B domain and the homeodomain (HD) probably
impede the DNA binding capacity of the protein.
To date, more than 60 point mutations, small deletions,
or insertions have been reported, clustered in the LIM and HD
domains of the LMX1B gene [14,15,20,21]. However, no mu-
tations in NPS patients have been detected in the COOH-ter-
minal third of the coding sequence of the LMX1B gene, sug-
gesting that mutations in this region are not inactivating [15].
Furthermore, transfection studies performed with NPS mu-
tants showed no significant dominant-negative effect on the
function of the wild-type LMX1B [21,26]. These findings sup-
port haploinsufficiency as the mechanism underlying patho-
genesis of NPS [20,21,27].
Mutations in LMX1B associated with NPS result in skel-
etal defects. All family members in this study who carried the
E97fsX105 mutation showed nail dysplasia and hypoplastic
patellae (Table 1), and most of them also had other skeletal
abnormalities. These common features were present with al-
most complete penetrance in the family. Some typical charac-
teristics were present at an early age, with members of the
family being able to predict who were carriers of the disease.
Indeed, their predictions agreed with our results concerning
the carriers of the mutation in the LMX1B gene. However,
renal, gastrointestinal, or ophthalmic involvement was more
variable within the family.
The expression of LMX1B in the kidney occurs exclu-
sively in podocytes [18]. Studies carried out in lmx1b knock-
out mice that mimic NPS showed an important impairment of
the glomerular basement membrane with expression of the
α3 and α4 chains of collagen IV and severe reduction of
podocin [18,19]. Importantly, lmx1b is also necessary for nor-
mal development of multiple tissues in the anterior segment
of the murine eye [19] Abnormalities in collagen fibrils in the
corneal stroma of lmx1b knockout mice have been observed.
The abnormal expression of collagen in homozygous lmx1b
knockout mice may explain the split in the glomerular base-
ment membrane in the kidney or the eye abnormalities [18,19]
possibly related with glaucoma. Surprisingly, lmx1b+/- mice
do not show an abnormal phenotype, indicating differences in
the lmx1b gene doses compared to humans. Recent immuno-
histological studies in NPS patients with severe glomerular
disease suggest a possible regulation of type III collagen by
LMX1B, while the homozygous mutations of LMX1B do not
appear to dramatically affect the expression of type IV col-
lagen chains and podocin in NPS patients.
Several well-known NPS studies have reported
cosegregation of OAG and NPS as a result of a pleiotropic
effect of the LMX1B gene in different families [1-3,14]. None
of these studies described the glaucomatous features in detail.
Some ocular abnormalities have been described in the knock-
out mouse model [19] such as an abnormal keratocan expres-
sion in the cornea, abnormal collagen fibrillogenesis, and a
reduction in the depth of the anterior chamber. The LMX1B
gene is also expressed in the trabecular meshwork but abnor-
malities in this tissue were not analyzed due to the short life
span of the knockout mouse. In addition, many other ocular
anomalies have been found sporadically in NPS patients, in-
cluding microcornea, sclerocornea, congenital cataracts, iris
processes, and pigmentation of the inner margin of the iris
(referred to as Lester’s sign) [1], but none of these is a spe-
cific trait of this syndrome.
Sweeney et al. [5] provided data from 123 NPS patients,
most of whom were visited at home. IOP was measured using
a Tonopen® and patients with IOP readings higher than 21
mmHg were advised to seek an ophthalmologist for further
investigation. The researchers reported a prevalence of glau-
coma and OHT of 9.6% and 7.2%, respectively. No other ad-
ditional information of note for a glaucoma diagnosis is avail-
able in their study. Bongers et al. [27] gave more reliable in-
formation. In their study, patients underwent gonioscopy and
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645Humphrey visual field analysis. They found glaucoma and
OHT in 35.3% of the patients and reported other ocular anoma-
lies, such as corneal anomalies, iris pigmentation, pigment
dispersion syndrome, and congenital cataracts. Lichter et al.
[1] reported OAG in 13 of 33 families, some of whom had
IOP higher than 30 mmHg and required filtration surgery.
Recently, a large study by Mimiwati [2] found glaucoma in
11.1% of his NPS population (33% of cases over the age of 40
years) and OHT in 11.1%. They reported an average age at
diagnosis of glaucoma in cases with apparently LMX1B caus-
ative mutations of 29.7 years, which is substantially below
the expected age at diagnosis for most cases of primary OAG.
The authors performed a comprehensive glaucoma screening
that included IOP, automated perimetry, and stereo disc pho-
tographs on all available family members.
New imaging techniques, such as OCT, are becoming
useful tools for the structural analysis of the optic disc and
peripapillary region, target sites of glaucomatous damage. The
most useful protocols are the Fast RNFL thickness and Fast
ONH, and several OCT parameters are presently being used
to evaluate the presence of glaucomatous optic disc damage
[22].
This is the first report of OCT data in NPS patients with
glaucoma or OHT. Surprisingly, all our study patients pre-
sented RNFL thickness measurements above normal. This in-
dicates that there is no loss of peripapillary nerve fiber bundles
and thus excludes the presence of glaucomatous optic neur-
opathy in our study population. These data correlated well with
the aspect of the optic disc and the perimetric results, except
in patient V-5, who presented arciform scotomata. This pa-
tient requires future perimetry testing after
phacoemulsification, as the cataract could skew the perimetry
results. One patient (V-1) presented with marked optic disc
cupping according to the examiner’s subjectivity; it was sup-
ported by the ONH OCT protocol.
Pachymetry-measured central corneal thickness has a sig-
nificant effect on the clinical management of patients with
glaucoma and glaucoma suspects [28]. In 1970, Ehlers [29]
published a paper suggesting that corneal thickness, another
biomechanical measurement of the eye, also affected IOP.
Technology to measure corneal thickness has developed over
time, and it was not until the publication of the Ocular Hyper-
tension Treatment Study (OHTS) [23] in 2002 that central cor-
neal thickness (CCT) was suggested to be an independent risk
factor for progression to initial glaucoma damage among in-
dividuals with OHT.
A thin pachymetry reading under 530 µm is considered a
risk factor for developing glaucoma in eyes with OHT. Re-
cent general practice guidelines recommend performing rou-
tine pachymetry and applying a correction factor to the IOP
measurements in order to avoid a confounding effect. An as-
sociation has even been proposed between CCT and the elas-
ticity of the lamina cribrosa. A very recent study [30] even
suggested an inverse correlation between CCT and optic disc
area. While thicker corneas may cause examiners to make a
slight overestimation of true IOP, their thickness may also in-
dicate the presence of a substantially smaller, and thus more
robust, ONH. Conversely, individuals with thinner corneas,
which may initiate a slight underestimation of true IOP, may
also be those with larger and more deformable optic discs.
Our study population corroborated this fact: All presented with
thick corneas and thick RNFL measurements whereas non-
NPS family members had “normal” CCTs. Whether thick CCT
belongs to the constellation of NPS traits is still unknown and
requires routine pachymetry in all these patients.
Our study population had OHT that fell within “normal”
limits of IOP readings after the automated pachymetry cor-
rections performed by the Ocuscan®, as they all had very thick
corneas. According to the OHTS [23], they all have a low risk
of developing OAG in the future. Moreover, their functional
and structural tests were normal, and medical treatment was
not required in these cases. It was actually withdrawn in sev-
eral cases except those with suspected glaucoma. We do not
know if any other NPS glaucoma cases described in the litera-
ture would have OHT or possible glaucoma after pachymetry
IOP correction.
The role that iris processes play in the development of
OHT is unknown, as they have classically been considered to
be innocuous, unlike the presence of high trabecular pigmen-
tation. Almost all our OHT and non-OHT NPS patients had a
myriad of iris processes in their anterior chamber angles. This
trait, therefore, seems to accompany the other NPS manifes-
tations, as has been described before, and is independent of
IOP.
In the family reported, some patients had OHT and kid-
ney or colon abnormalities. The 30% proportion of the family
who had gastrointestinal and renal abnormalities of NPS is
similar to previously reported data. The presence of glaucoma
or OHT has been estimated to be near 30% in other studies,
but in this family 70% of the NPS patients had OHT, indicat-
ing that this is a significant feature in the family. OHT was not
a constant sign and its severity did not depend on the age of
the patient or the degree of systemic disease. The index pa-
tient in this family was one of the most affected individuals,
with severe skeletal anomalies and nephropathy, though she
did not have OHT.
We conclude that NPS shows a high inter- and intrafamily
heterogeneity. The pathogenesis of OAG or OHT in these pa-
tients is still not well understood, and it shows no correlation
with the severity of other systemic anomalies. OHT was not
present in unaffected individuals, and it seems to be a genuine
pleiotropic effect of the LMX1B mutation in this family.
Caution should be taken when diagnosing the presence
of glaucoma in persons with NPS, and it should be corrected
by pachymetry. OCT is a useful tool for the diagnosis of glau-
comatous optic nerve and RNFL pathology, especially in those
cases with unclear perimetric testing. We encourage other in-
vestigators to perform pachymetry and OCT in NPS patients
in order to corroborate the presence of a higher thickness of
the corneal and retinal nerve tissues. Surprisingly both factors
could, in a certain way, be considered as “protective” ocular
mechanisms against the presence of glaucomatous optic nerve
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646damage. There is still a long way to go in the establishment of
a correlation between glaucoma and other ocular manifesta-
tions of this syndrome, such as the presence of multiple iris
processes. Ultrastructural studies are needed to establish
whether both renal and ophthalmic anomalies belong to the
same form of inheritable connective tissue disorder.
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